A detailed history of Clearbridge Investments, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Clearbridge Investments, LLC holds 6,019,024 shares of JNJ stock, worth $1 Billion. This represents 0.74% of its overall portfolio holdings.

Number of Shares
6,019,024
Previous 6,019,024 -0.0%
Holding current value
$1 Billion
Previous $880 Million -0.0%
% of portfolio
0.74%
Previous 0.74%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $28.6 Million - $31.2 Million
197,850 Added 3.4%
6,019,024 $880 Million
Q1 2024

May 13, 2024

SELL
$155.22 - $162.74 $72 Million - $75.5 Million
-464,010 Reduced 7.38%
5,821,174 $921 Million
Q4 2023

Feb 09, 2024

BUY
$145.6 - $158.88 $7.4 Million - $8.07 Million
50,822 Added 0.82%
6,285,184 $985 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $83.5 Million - $93.6 Million
-536,169 Reduced 7.92%
6,234,362 $971 Million
Q2 2023

Aug 11, 2023

BUY
$154.35 - $166.11 $101 Million - $109 Million
657,051 Added 10.75%
6,770,531 $1.12 Billion
Q1 2023

May 12, 2023

SELL
$151.05 - $180.26 $40.1 Million - $47.8 Million
-265,164 Reduced 4.16%
6,113,480 $948 Million
Q4 2022

Feb 10, 2023

BUY
$160.2 - $179.79 $56.1 Million - $63 Million
350,245 Added 5.81%
6,378,644 $1.13 Billion
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $10.4 Million - $11.6 Million
64,682 Added 1.08%
6,028,399 $985 Million
Q2 2022

Aug 11, 2022

BUY
$168.19 - $186.01 $33 Million - $36.5 Million
196,363 Added 3.4%
5,963,717 $1.06 Billion
Q1 2022

May 13, 2022

SELL
$158.14 - $179.59 $47.9 Million - $54.4 Million
-302,964 Reduced 4.99%
5,767,354 $1.02 Billion
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $31.6 Million - $35 Million
-202,477 Reduced 3.23%
6,070,318 $1.04 Billion
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $31 Million - $34.4 Million
191,851 Added 3.15%
6,272,795 $1.01 Billion
Q2 2021

Aug 13, 2021

SELL
$159.48 - $171.07 $16.3 Million - $17.5 Million
-102,202 Reduced 1.65%
6,080,944 $1 Billion
Q1 2021

May 13, 2021

SELL
$153.07 - $170.48 $15.9 Million - $17.7 Million
-103,722 Reduced 1.65%
6,183,146 $1.02 Billion
Q4 2020

Feb 10, 2021

SELL
$137.11 - $157.38 $52.3 Million - $60 Million
-381,388 Reduced 5.72%
6,286,868 $989 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $29.9 Million - $32.8 Million
-212,990 Reduced 3.1%
6,668,256 $993 Million
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $24.1 Million - $29 Million
186,736 Added 2.79%
6,881,246 $968 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $510 Million - $707 Million
-4,589,112 Reduced 40.67%
6,694,510 $878 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $5.71 Million - $6.55 Million
44,758 Added 0.4%
11,283,622 $1.65 Billion
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $88.7 Million - $99.3 Million
698,691 Added 6.63%
11,238,864 $1.45 Billion
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $120 Million - $132 Million
911,730 Added 9.47%
10,540,173 $0
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $6.11 Million - $6.79 Million
48,582 Added 0.51%
9,628,443 $1.35 Billion
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $44.2 Million - $53.2 Million
-359,577 Reduced 3.62%
9,579,861 $1.24 Billion
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $39.6 Million - $46.5 Million
-325,686 Reduced 3.17%
9,939,438 $1.37 Billion
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $3.81 Million - $4.2 Million
31,895 Added 0.31%
10,265,124 $1.25 Billion
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $82.1 Million - $97.2 Million
656,344 Added 6.85%
10,233,229 $1.31 Billion
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $10.1 Million - $11 Million
76,918 Added 0.81%
9,576,885 $1.34 Billion
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $542,220 - $566,971
4,188 Added 0.04%
9,499,967 $1.24 Billion
Q2 2017

Aug 14, 2017

BUY
N/A
9,495,779
9,495,779 $1.26 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.